ANDHealth News

Another year, another successful mission to HTLH USA! Over 60 Australians took Las Vegas by storm this week – making new connections, showcasing their innovations and gaining insights into international expansion.

Five digital health technologies tackling some of Australia’s biggest health challenges are set to share a total funding injection of $3.25M from the Medical Research Future Fund (MRFF), after being awarded stage-two funding in the country’s leading digital and connected health accelerator program, ANDHealth+.

Delivered in partnership by Brandon BioCatalyst and ANDHealth, CUREator+ supports the translation and commercial development of promising biomedical and digital health technologies.

The Federal Government has released the final report of Australia’s Health Technology Assessment (HTA) Review.

A joint initiative between ANDHealth and the Therapeutic Goods Administration (TGA) will continue providing regulation and registration support for digital medical software companies looking to commercialise new products that can help improve health outcomes for Australian patients.

ANDHealth has today announced the extension of the Victorian Connected Health Innovation and Commercialisation Centre (CHICC) initiative for a further 12 months, off the back of the substantial growth in the local industry over the past five years.

Six potentially life-changing digital health technologies are set to receive non-dilutive funding through the Medical Research Future Fund (MRFF) as part of the ANDHealth+ program.

ANDHealth is delighted to see CEO Bronwyn Le Grice and Chief Product & Partnerships Officer Grace Lethlean recognised in the Australian Financial Review’s 2024 Women in Leadership list, two of just six health sector leaders recognised in this year’s list.

The New South Wales Budget 2024-25 was announced this week, and the government continues to invest in NSW’s health system and digital health infrastructure.

The CUREator+ Dementia and Cognitive Decline incubator program, a partnership between Brandon BioCatalyst, ANDHealth and Dementia Australia, has opened its first funding round.

ANDHealth has welcomed the 2024 Federal Budget’s ongoing commitment to health and medical research and connected health infrastructure.

The WA State Budget handed down last week includes large investments in health and mental health, with a further $3.2b to boost the capacity of Western Australian hospitals, invest in more nurses and doctors, and improve access to quality care.

Australia’s leading digital health commercialisation firm, ANDHealth, in partnership with LaunchVic, has revealed the highly-anticipated 2024 ACTIVATE accelerator cohort, which identifies 15 local startups set to contribute to Victoria’s growing digital health sector.

The Victorian Budget has just been announced and while there is more funding for hospitals and the health system, debt will continue to rise overall, with net debt going from $156.2bn by the end of the next financial year to $187.8bn by June 2028.

ANDHealth has today welcomed the Albanese Government’s commitment to develop a unified National Health and Medical Research Strategy to guide investment into health and medical research.

The $15bn National Reconstruction Fund has today prioritised ‘digital health’ as a key pillar of its new Medical Science Co-Investment Plan.

This year’s International Women’s Day theme is very close to our hearts – Count Her In: Invest in Women. Accelerate Progress. Thank you to Gabrielle Provost (Connected-Care.Io), Georgia Downing (Gild), Jeannie-Marie Noyce (Brenna), Helen Souris (Cardihab) and Santosh Kaur (SmartHeal) for participating in our special International Women’s Day 2024 report.

Brandon BioCatalyst’s CUREator, in partnership with ANDHealth, is set to deliver a BioMedTech Incubator (BMTI) focused on developing research discoveries and medical innovations with commercial potential to address dementia and cognitive decline thanks to a $50m grant from the Federal Government.

An independent report into Australian digital health commercialisation programs has highlighted the considerable impact of ANDHealth on core economic metrics when benchmarked against comparable accelerators in general technology, deep technology, and health technology.

An AI-powered system enabling improved treatment of macular degeneration, one of the biggest causes of preventable blindness, and an AI-supported wearable device seeking to prevent post-partum haemorrhage, a leading cause of maternal deaths, are among four digital health technologies set to receive non-dilutive funding through the Medical Research Future Fund (MRFF).

We’re thrilled to announce that applications for ANDHealth+ cohort 4 will be opening soon! ANDHealth+ is a unique, non-equity-taking program offering digital health companies non-dilutive funding, support from a world-class team, and access to an international network of experts.

Australian digital health companies supported by ANDHealth have reached a new milestone, impacting over 1 million patients since 2018.

ANDHealth, Australia’s leading commercialisation organisation, has today been recognised as one of the top 10 most innovative companies in Australia in the Health Industries category in the Australian Financial Review’s BOSS annual Most Innovative Companies list.

Five of Australia’s most promising digital health companies have been successfully accepted into the market-leading ANDHealth+ commercialisation program and will scale their products nationally and internationally.

Expressions of Interest for CUREator+, a newly created $50 million program by Brandon BioCatalyst and ANDHealth, are now open.

Australia’s leading digital health commercialisation organisation, ANDHealth, has today announced the extension of its partnership with the Therapeutic Goods Administration (TGA) to provide ongoing regulatory guidance to Australia’s rapidly growing digital health and software-enabled sector.

New research from Australian digital health commercialisation firm ANDHealth has revealed that a lack of digital health specialised investors and limited access to capital remain the most significant impediments to commercialising new health technologies in Australia.

ANDHealth Activate, the first dedicated digital and connected health accelerator program, supported by LaunchVic and designed specifically for the Victorian SME community today announced the 15 digital and digitally enabled medical technology companies that will benefit from this new program.

ANDHealth has welcomed a federal budget commitment of $392m towards a new Industry Growth Program for SMEs and startups to commercialise Australian innovations aligned to the National Reconstruction Fund, and $950m in new investment to improve the My Health Record system and other national digital health infrastructure.

Chicago ARC Executive Director Kate Merton and ANDHealth CEO and Managing Director Bronwyn Le Grice today announced an exciting new partnership to connect Australia’s best and brightest digital health companies with U.S. partners and market opportunities through the Chicago ARC and its healthcare partner network.

The Victorian Connected Health Innovation and Commercialisation Centre (CHICC), powered by ANDHealth, was formally opened today by the Minister for Industry and Innovation, The Hon Ben Carroll MP.

$3.7M from the Australian Government’s Medical Research Future Fund (MRFF) will be invested into four high-growth potential digital health companies, supporting them to develop and release new products and expand into global markets, through digital health commercialisation program, ANDHealth+.

Federal investment creates a combined funding capability of $115m across programs managed by Brandon BioCatalyst & ANDHealth.

Research Australia announced that ghd is the 2022 recipient of the Advocacy Award, sponsored by AbbVie, for their commitment to breast cancer research and raising awareness of the disease, particularly among younger women. ANDHealth CEO and Managing Director, Bronwyn Le Grice, was recognised as a highly commended finalist in the Advocacy category.

ANDHealth, Australia’s leading digital health commercialisation organisation, today announced the five companies selected for the second cohort of the ANDHealth+ program, funded by the Australian Government’s Medical Research Future Fund (MRFF).

ANDHealth, Australia’s leading digital health commercialisation organisation, has today launched the WA Connected Health Commercialisation Initiative, in collaboration with the WA Life Sciences Innovation Hub, a partnership with MTPConnect, the WA Government Department of Jobs, Tourism, Science and Industry, and the University of Western Australia.

ANDHealth, Australia’s leading digital health commercialisation organisation, has successfully secured $1.4M in funding from LaunchVic to establish a novel accelerator program for high-growth potential digital health startups.

Australia must commit to sustained digital health investment to position itself as a global destination for digital health innovation and commercialisation, according to ANDHealth’s latest State of the Industry report, The Awakening Giant: The Rise of Australia’s Evidence-Based Digital Health Sector.

ANDHealth is proud to announce that CEO and Managing Director, Bronwyn Le Grice, has been recognised in the 2022 Brilliant Women in Digital Health Awards as one of 25 women honoured for outstanding achievements and contributions in digital health. Profiling the careers and stories of award recipients aims to inspire future leaders in the health and aged care sectors and contribute to greater gender diversity in digital health.

ANDHealth, Australia’s leading digital health commercialisation organisation, in partnership with the Victorian Government, today announced it has received $2.4M from the Australian Medtech Manufacturing Centre and Biotechnology Fund to create the Victorian Connected Health Innovation & Commercialisation Centre (CHICC).

Australia’s leading digital health commercialisation company ANDHealth today announced that Telstra Health has joined its cooperative digital health commercialisation organisation to support the growth of Australia’s digital health industry.

Congratulations to ANDHealth Core Partner Planet Innovation for their recent success at the 2022 Victorian Manufacturing Hall of Fame Awards.

ANDHealth, Australia’s leading digital health commercialisation organisation, today announced the extension of its partnership with the Therapeutic Goods Administration (TGA) to support Australia’s fast-growing digital health sector.

ANDHealth welcomes investments from the NSW and Queensland Governments that will drive growth and create jobs in emerging high-value industries such as digital technology, medtech, the clean economy, advanced manufacturing and biomedical technology.

At the recent Digital Health Festival, ANDHealth CEO Bronwyn Le Grice shared the boom and bust stories of digital health unicorns and presented a realistic set of principles for digital health start-ups to keep in mind as they go on their growth journey. Here are some of the key insights from her presentation.

Thank you to the great speakers and panellists who shared their insights with 102 people at our summit, in person and virtually on Tuesday 24 May 2022.

ANDHealth has commended the Australian Government for putting in place a broad budget which balances immediate cost of living challenges alongside significant funding towards a “stronger future” for Australia. Delivered against the backdrop of current global and national challenges, ANDHealth supports the budget’s focus on strengthening the health and medical research landscape and providing further investment in the infrastructure necessary to deliver digital health initiatives.

ANDHealth is delighted to announce the appointment of leading digital health executive and CEO and Group Managing Director of Alcidion Group Limited (ASX:ALC), Kate Quirke, to its Board of Directors in the role of Non-Executive Director.

Life Sciences WA, supported by ANDHealth and MTPConnect, has been awarded one of eight X-TEND WA program grants to deliver a unique program to enhance investment opportunities and foster commercialisation of digital health companies in WA through a bespoke ‘Investment Series’ education program.

Australia’s only not-for-profit digital health commercialisation organisation, ANDHealth today announced the five companies selected to take part in its Medical Research Future Fund (MRFF) funded ANDHealth+ program.

ANDHealth is proud to announce the appointment of its International Investment Advisory Committee (IIAC), which will provide critical insights and frontline industry experience to the MRFF funded ANDHealth Digital Health Accelerator Fund and associated ANDHealth+ program.

ANDHealth is delighted to announce that CEO and Managing Director, Bronwyn Le Grice, has been appointed by the Hon Greg Hunt, the Australian Minister for Health and Aged Care, as a Member of the Council of the National Health and Medical Research Council (NHMRC) for the 2021-2024 triennium.

ANDHealth, Australia’s leading digital health commercialisation organisation, today opened applications for its flagship program, ANDHealth+, after receiving a $19.75M funding injection from the Medical Research Future Fund (MRFF).

Bronwyn Le Grice, CEO and Managing Director of ANDHealth, has been named by the Pearcey Foundation as its 2021 Victorian Pearcey Entrepreneur Award recipient. The peer-selected awards recognise an individual who has made an outstanding contribution to the Australian information, communication and digital technology sector in their chosen industry in their state. And has taken a risk, made a difference and been an inspiration to others.

ANDHealth, Australia’s leading digital health commercialisation organisation, today announced a partnership with the Therapeutic Goods Administration (TGA) to support Australia’s digital health companies navigate the regulatory environment for ‘software as a medical device’ (SaMD). This initiative will build the capability of Australian SMEs to design and deliver robust clinical trials and evidence to support the safety and efficacy of digital health products.

ANDHealth, Australia’s leading digital health commercialisation organisation, has today announced it has been successful in securing $19.75M in funding received from the Australian Federal Government under the Medical Research Future Fund (MRFF) Early Stage Translation and Commercialisation Support program.

ANDHealth, Australia’s leading digital health commercialisation company, is excited to be named alongside Australia’s pioneer deep tech incubator, Cicada Innovations, as a delivery partner for the NSW Health Medical Device Commercialisation Training Program (MDCTP). The free training program aims to fast-track innovative ideas that will revolutionise the healthcare sector, improve patient outcomes, and provide economic opportunities for emerging medtech businesses in NSW.

ANDHealth welcomes funding from the NSW Government including further investment into entrepreneurship and innovation, virtual care, telehealth, e-prescribing and electronic medical records to support the growth of Australia’s nascent digital health sector. This recognition and investment marks a critical step in advancing our digital health system. However, industry growth hinges on structures which look beyond health IT to evidence-based, connected, and data-driven products proven to directly impact patient outcomes.

ANDHealth congratulates the South Australian Government for their leadership in transforming the economy and health of their community via technology, evidenced in the 2021 – 2022 budget announcement.

ANDHealth today announced that Roche Australia – a world leader in innovation and research-focused healthcare – has joined ANDHealth’s cooperative digital health commercialisation initiative as a Corporate Member to support the development and growth of Australia’s local digital health ecosystem.

The 2021-22 Federal Budget included a series of broad reaching initiatives which will benefit Australia’s nascent digital health sector and broader health and medical research sector, drive economic recovery and support better health outcomes for all Australians.

ANDHealth, Australia’s leading digital health commercialisation organisation, today announced a partnership with the global Digital Therapeutics Alliance to accelerate understanding, adoption and integration of clinically validated digital therapeutics (DTx) in Australia.

ANDHealth, Australia’s leading organisation in the commercialisation of digital health technologies, today announced a joint effort with the Anthem Digital Incubator to facilitate and accelerate US market access and uptake for Australian digital health companies and their products and services.

The $38 million Targeted Translation Research Accelerator (TTRA) initiative is a four-year funding opportunity of the Medical Research Future Fund, aimed at improving the prevention, diagnosis, management and treatment of diabetes, cardiovascular disease and their related complications in Australia.

Grace Lethlean, a passionate enabler of commercial potential in digital health has been named one of Australia’s official Superstars of STEM.

ANDHealth, Australia’s leading organisation in accelerating the commercialisation of evidence-based digital health technologies, today announced new outcomes achieved by the Australian companies which participated in the two-year pilot of the ANDHealth+ Program.

On behalf of the Board of Directors and Members, ANDHealth is delighted to present the 2020 annual report which highlights the remarkable activities, outcomes and impact of ANDHealth for FY20.

Dr Charlie Day (D.Phil (Oxon), B.E. (Hons), B.A., GAICD) has been elected as a Non-Executive Director of the Board of leading digital health accelerator, ANDHealth.

ANDHealth today welcomed comments made by Minister for Health, The Hon Greg Hunt MP, presenting at the HLTH conference early this morning.

Find out more about the new changes at ANDhealth

ANDHealth’s New Normal: Redefining the way we work, just the way we have redefined commercialisation acceleration and incubation.

This week saw one of the most anticipated Federal budgets in memory handed down.

ANDHealth, Australia's leading organisation in accelerating the commercialisation of evidence-based digital health technologies, today announced new outcomes achieved by the Australian companies which participated in the two-year pilot of the ANDHealth+ Program.

ANDHealth has been funded to deliver its unique commercialisation framework and expertise to Western Australian digital health companies throughout 2020, alongside the Telethon Kids Institute, supported by the Western Australian State Government’s New Industries Fund.

ANDHealth’s 2020 Winter Summit – The New Normal: Digital Health in a Post-COVID World – has just concluded, with some great insights for Australian digital health companies.

ANDHealth is delighted to announce that the Victorian State Government will be supporting ANDHealth’s Winter Summit, The New Normal: Digital Health in a Post-COVID World.

Two companies which graduated from novel digital health accelerator ANDHealth’s globally unique ANDHealth+ program have received government funding via the BioMedTech Horizons (BMTH) program.

The BRIGHT workshop is a fast-moving, interactive workshop designed to equip you with practical skills, a proven framework and powerful real-world insights into the innovation and commercialisation process.

Three years in the making, we are proud to bring you our brand new report – Digital Health: The Sleeping Giant of Australia’s Health Technology Industry.

MTPConnect is launching the $32 million Researcher Exchange and Development within Industry (REDI) initiative, working in collaboration with eight leading industry and research partners

Today, Bronwyn Le Grice, Founder and CEO of Australia’s only dedicated digital health accelerator and commercialisation support organisation, ANDHealth, has been honoured with the BioMelbourne Network Most Valuable Women in Leadership Award.

This week, ANDHealth CEO Bronwyn Le Grice spoke with Perth Angels, one of the most active early-stage investor groups in Australia, about the opportunities for digital health in Australia and globally, and why the COVID-19 pandemic presents opportunities (and challenges) for digital health companies and investors.

ANDHealth is delighted to present the updated Cohort Company Outcomes reported to ANDHealth as at March 31 2020.

Despite this being the life sciences industry’s ‘finest hour’ as it pivots to fast track COVID-19 vaccines, treatment and diagnostics and digital health solutions, the sector’s pre-revenues companies are calling for support to keep their highly-skilled 65,000 jobs.

Important changes are happening in the regulation of digital health and medical devices in the EU.

At ANDHealth, we are especially proud of our long-standing relationship with Planet Innovation and its award-winning BRIGHT program, which we have now brought to nearly 60 Australian digital health companies. But where did BRIGHT begin?

New research by ANDHealth, Australia’s only female-founded health accelerator andcommercialisation support organisation, has identified a substantial lack of gender diversity in theinnovation ecosystem.

ANDHealth, Australia’s leading digital and connected health accelerator, is delighted to announce anew partnership with leading deep tech incubator, Cicada Innovations and NSW Health, which willsee the world-class B.R.I.G.H.T. for Digital Health program delivered in NSW in 2020.

ANDHealth will renew its commitment to turning innovative digital health ideas into commercial reality, after being named a beneficiary of a major new grant through its founding partner MTPConnect.

It’s that time of year again… I’m not sure about you, but the summer Festive season does seem to come around at an alarming speed every year, and so I find myself sitting here reflecting upon another year at the fast-moving non-profit that is ANDHealth.

ANDHealth today announced the appointment of leading healthcare communicator, analyst and strategist, Iain Scott, to the role of VP Stakeholder Engagement.

Leading Australian health accelerator announces key commercial outcomes at global HLTH Conference

Presagen, a company developing and deploying scalable, unbiased artificial intelligence products, has today launched a new service focused on revolutionising the development of AI products in healthcare. Presagen made the announcement at the global conference for healthcare disruption, HLTH, where they are participating in a delegation led by leading digital health accelerator, ANDHealth.

A delegation of more than 25 executives representing some of Australia’s leading digital health companies will this week attend HLTH – the world’s fastest growing conference dedicated to health innovation and disruption.

One of Australia’s most experienced health sector executives, Gavin Fox-Smith, has been appointed the new Chair of leading digital health accelerator, ANDHealth, after Dr Anna Lavelle announced her retirement as Chair of the Board.

ANDHealth is delighted to present the 2019 annual report which highlights the remarkable activities, outcomes and impact of ANDHealth for FY2019.

As Australia’s only dedicated provider of digital health commercialisation support, ANDHealth is seeking input from digital health innovators and companies to identify gaps, challenges and opportunities in digital health commercialisations.

ANDHealth is delighted to partner with a consortium of leading medical research institutes and universities in Western Australia, led by the Telethon Kids Institute, as part of the State’s first Digital Health Accelerator Program.

ANDHealth has been awarded $250,000 to deliver a bespoke intensive Digital Health Market Success Bootcamp for up to 40 Australian digital health companies.

Exploring the strengths, opportunities, constraints and barriers to the commercialisation of evidence-based digital health technologies in Australia.